Regulation of the Hippo pathway and its role in uveal melanoma
Hippo通路的调节及其在葡萄膜黑色素瘤中的作用
基本信息
- 批准号:8340411
- 负责人:
- 金额:$ 38.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:ApoptosisBiochemicalBiologyCell CountCell ProliferationCell Surface ReceptorsCutaneous MelanomaDevelopmentDiseaseEyeFrequenciesG-Protein-Coupled ReceptorsGene ExpressionGeneticGenetic TranscriptionGoalsHumanKnowledgeLaboratoriesLigandsLiverLysophospholipidsMalignant NeoplasmsMammalian CellMolecularMutateMutationNeoplasm MetastasisOrgan SizePathway interactionsPhosphorylationPhosphotransferasesPlayProtein DephosphorylationProteinsRas/RafRegulationRoleSignal PathwaySignal TransductionSignaling MoleculeSphingosineStem cellsTestingTumor Suppressor ProteinsUveal Melanomabasecell motilityeffective therapyextracellularinsightlimitinlysophosphatidic acidself-renewalsphingosine 1-phosphatestemtherapeutic targettumortumorigenesis
项目摘要
DESCRIPTION (provided by applicant): The Hippo tumor suppressor pathway plays a crucial role in regulating organ size by inhibiting cell proliferation and promoting apoptosis, and limitin stem/progenitor cell self- renewal and expansion. The YAP/TAZ transcription co-activators are the major downstream effectors of the Hippo pathway. Despite extensive studies, upstream signals regulating the Hippo pathway are unknown. Currently, no extracellular ligand or cell surface receptor has been identified to regulate the mammalian Hippo-YAP. Our preliminary studies have discovered that lysophosphatidic acid (LPA) and sphingosine 1- phosphophate (S1P) are important signaling molecules that regulating the Hippo pathway. LPA and S1P act through their respective G-protein coupled receptors (GPCRs) to activate YAP. Both LPA and S1P have been implicated in cancer development and metastasis. Notably, activating mutations of Gq/11 are frequently found (83%) in uveal melanoma, which is the most common intraocular tumor in the eye with strong propensity of metastasis into the liver. Our preliminary study showed that active Gq/11 potently stimulates YAP activity. The major goals of this proposal are to investigate the mechanism of Hippo-YAP regulation by GPCR and to determine the functional significance of YAP/TAZ activation in the biology of LPA, S1P and other extracellular signals. Moreover, we will investigate the pathophysiological function of YAP/TAZ activation in the development of uveal melanoma and aim to provide scientific basis for treatment of this disease.
PUBLIC HEALTH RELEVANCE: The Hippo signaling pathway plays a major role in organ size regulation by controlling cell number and has also been implicated in human cancer. Preliminary studies from the PI's laboratory have identified the first extracellular signals and cell surface receptors that regulate the Hippo pathway, and suggested a critical role of the Hippo pathway in uveal melanoma, which is the most common intraocular tumor in the eye. The goal of this proposal is to gain knowledge of Hippo-YAP pathway regulation and its role in uveal melanoma development.
描述(由申请人提供):河马肿瘤抑制途径通过抑制细胞增殖和促进凋亡在调节器官大小中起着至关重要的作用,并限制了限制茎/祖细胞/祖细胞自我更新和扩张。 YAP/TAZ转录共激活因子是河马途径的主要下游效应子。尽管进行了广泛的研究,但调节河马途径的上游信号尚不清楚。目前,尚未鉴定出细胞外配体或细胞表面受体来调节哺乳动物的河马-YAP。我们的初步研究发现,溶物磷脂酸(LPA)和1-磷酸盐(S1P)是调节河马途径的重要信号分子。 LPA和S1P通过其各自的G蛋白偶联受体(GPCR)起作用以激活YAP。 LPA和S1P都与癌症的发展和转移有关。值得注意的是,在卵巢黑色素瘤中经常发现GQ/11的激活突变(83%),这是眼睛中最常见的眼内肿瘤,转移倾向很强。我们的初步研究表明,主动GQ/11有效刺激YAP活性。该提案的主要目标是研究GPCR通过GPCR调控的机理,并确定LPA,S1P和其他细胞外信号在生物学中YAP/TAZ激活的功能意义。此外,我们将研究YAP/TAZ激活在卵巢黑色素瘤发展中的病理生理功能,并旨在为治疗这种疾病提供科学基础。
公共卫生相关性:河马信号通路通过控制细胞数量在器官大小调节中起着重要作用,并且也与人类癌症有关。来自PI实验室的初步研究已经确定了调节河马途径的第一个细胞外信号和细胞表面受体,并提出了河马途径在卵巢黑色素瘤中的关键作用,这是眼睛中最常见的眼内肿瘤。该提议的目的是了解河马途径调节及其在紫菜素黑色素瘤发育中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kun-Liang Guan其他文献
Kun-Liang Guan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kun-Liang Guan', 18)}}的其他基金
Functional interplay between Hippo and estrogen receptor ESR1
Hippo 和雌激素受体 ESR1 之间的功能相互作用
- 批准号:
10339901 - 财政年份:2022
- 资助金额:
$ 38.75万 - 项目类别:
Molecular Mechanism and Therapy for Ocular Melanoma
眼部黑色素瘤的分子机制及治疗
- 批准号:
9453662 - 财政年份:2017
- 资助金额:
$ 38.75万 - 项目类别:
Molecular Mechanism and Therapy for Ocular Melanoma
眼部黑色素瘤的分子机制及治疗
- 批准号:
9328539 - 财政年份:2017
- 资助金额:
$ 38.75万 - 项目类别:
The mTOR and Hippo pathway in cell growth and cancer
mTOR 和 Hippo 通路在细胞生长和癌症中的作用
- 批准号:
9752481 - 财政年份:2015
- 资助金额:
$ 38.75万 - 项目类别:
The mTOR and Hippo pathway in cell growth and cancer
mTOR 和 Hippo 通路在细胞生长和癌症中的作用
- 批准号:
9120339 - 财政年份:2015
- 资助金额:
$ 38.75万 - 项目类别:
Regulation of the Hippo pathway and its role in uveal melanoma
Hippo通路的调节及其在葡萄膜黑色素瘤中的作用
- 批准号:
8722567 - 财政年份:2012
- 资助金额:
$ 38.75万 - 项目类别:
Regulation of the Hippo pathway and its role in uveal melanoma
Hippo通路的调节及其在葡萄膜黑色素瘤中的作用
- 批准号:
8529541 - 财政年份:2012
- 资助金额:
$ 38.75万 - 项目类别:
Protein phosphorylation and growth factor function
蛋白质磷酸化和生长因子功能
- 批准号:
7892688 - 财政年份:2009
- 资助金额:
$ 38.75万 - 项目类别:
Regulation and function of the YAP transcription co-activator oncoprotein
YAP转录辅激活癌蛋白的调控和功能
- 批准号:
8022881 - 财政年份:2008
- 资助金额:
$ 38.75万 - 项目类别:
Regulation and function of the YAP transcription co-activator oncoprotein
YAP转录辅激活癌蛋白的调控和功能
- 批准号:
8627562 - 财政年份:2008
- 资助金额:
$ 38.75万 - 项目类别:
相似国自然基金
入核效应蛋白SidW的生化及生物学功能
- 批准号:32370196
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
军团菌真核样丝/苏氨酸激酶效应蛋白的生化及生物学功能研究
- 批准号:32170182
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
壬基酚聚氧乙烯醚(NPnEO)废水生化处理过程中内分泌干扰毒性变化规律及微生物学机制
- 批准号:51908276
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
帕金森病合并轻度认知障碍不同亚型的脑影像和血液生化研究
- 批准号:31700960
- 批准年份:2017
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
嗜肺军团菌OTU家族效应蛋白生化及生物学功能研究
- 批准号:31770149
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Molecular Mechanisms of Mitochondrial Biogenesis
线粒体生物发生的分子机制
- 批准号:
10735778 - 财政年份:2023
- 资助金额:
$ 38.75万 - 项目类别:
Elucidating the role of DCAF7 on hematopoietic stem cell maintenance
阐明 DCAF7 对造血干细胞维持的作用
- 批准号:
10785443 - 财政年份:2023
- 资助金额:
$ 38.75万 - 项目类别:
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:
10644874 - 财政年份:2023
- 资助金额:
$ 38.75万 - 项目类别:
Biomimetic Vascular Matrix for Vascular Smooth Muscle Cell Mechanobiology and Pathology
用于血管平滑肌细胞力学生物学和病理学的仿生血管基质
- 批准号:
10586599 - 财政年份:2023
- 资助金额:
$ 38.75万 - 项目类别:
Defining cell intrinsic and extrinsic regulators of ferroptosis in pancreatic cancer
定义胰腺癌铁死亡的细胞内在和外在调节因子
- 批准号:
10679812 - 财政年份:2023
- 资助金额:
$ 38.75万 - 项目类别: